Deferred Revenue (Tables)

5 Months Ended

Dec. 31, 2017

Deferred Revenue Disclosure [Abstract]

Schedule of Deferred Revenue Activity

The following is a summary of the Company’s deferred revenue activity for the five months ended December 31, 2017 and the years ended July 31, 2017 and 2016:

(in thousands)	OORT			BED			Other Opioid Treatments		Total
Balance as of July 31, 2016		$	—	$	1,000		$	1,600	$	2,600
Recognized as revenue		—		(39		)	—		(39		)
Balance as of July 31, 2017		—		961			1,600		2,561
Recognized as revenue		—		(66		)	—		(66		)
Balance as of December 31, 2017		$	—	$	895		$	1,600	$	2,495

Deferred Revenue, by Arrangement

The remaining $2.1 million was recorded as a long-term liability as of December 31, 2017, as detailed in the following table:

(in thousands)	OORT			BED		Other Opioid Treatments		Total
Current portion		$	—	$	379	$	—	$	379
Long-term portion		—		516		1,600		2,116
Total		$	—	$	895	$	1,600	$	2,495